印度槓上WHO,為了治療新冠肺炎的藥物 | 陳豐偉 - vocus
今天收到訊息,印度全國律師聯合會對WHO首席科學家(Chief Scientist) Dr Soumya Swaminathan送出法律說明書(legal note),認為她忽略有意義的科學證據,散播不實資訊、意圖讓印度人民不配合政府為抑制新冠肺炎疫情廣為散發ivermectin的公衛行動。 精選專題, ivermectin, WHO
今天收到訊息,印度全國律師聯合會對WHO首席科學家(Chief Scientist) Dr Soumya Swaminathan送出法律說明書(legal note),認為她忽略有意義的科學證據,散播不實資訊、意圖讓印度人民不配合政府為抑制新冠肺炎疫情廣為散發ivermectin的公衛行動。 精選專題, ivermectin, WHO
Cannot get data from URL
Cannot get data from URL
Facebookにログインして、友達や家族と写真や近況をシェアしましょう。
Studies on whether ivermectin is beneficial in treating COVID-19 patients haven't been conclusive, and health officials have warned people not to self-medicate. But multiple large trials are continuin
Cannot get data from URL
網傳「服用伊維菌素後,巴西、秘魯、印度疫情大幅下降」的訊息。專家指出,過去有部分文章指稱伊維菌素好像對控制新冠肺炎有幫助,但從比較嚴謹的醫學角度、實證醫學看來,目前沒有足夠證據認為伊維菌素有幫助,所以未被納入正式的治療指引。專家表示,即使是在真實世界進行的試驗,仍要看該研究做得夠不夠嚴謹,需考量很多
The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.